+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029

  • PDF Icon

    Report

  • 229 Pages
  • July 2025
  • Region: Global
  • TechNavio
  • ID: 5398478
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The chronic obstructive pulmonary disease drugs market is forecasted to grow by USD 7.84 billion during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the chronic obstructive pulmonary disease drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of copd, strong pipeline and new drug approvals, and growing demand for fixed-dose combinations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The chronic obstructive pulmonary disease drugs market is segmented as below:

By Product

  • Combination therapy
  • Monotherapy

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Route Of Administration

  • Inhalation
  • Oral
  • Injectable

By Disease Type

  • Chronic bronchitis
  • Emphysema

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the expanding research in curative approaches as one of the prime reasons driving the chronic obstructive pulmonary disease drugs market growth during the next few years. Also, advances in drug delivery devices and expansion of inhalation therapies will lead to sizable demand in the market.

The report on the chronic obstructive pulmonary disease drugs market covers the following areas:

  • Chronic Obstructive Pulmonary Disease Drugs Market sizing
  • Chronic Obstructive Pulmonary Disease Drugs Market forecast
  • Chronic Obstructive Pulmonary Disease Drugs Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic obstructive pulmonary disease drugs market vendors that include AstraZeneca Plc, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, SHIONOGI Co. Ltd., Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Theravance Biopharma Inc., Viatris Inc., and Phillips Medisize. Also, the chronic obstructive pulmonary disease drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023
Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Route of Administration segment analysis 2019 - 2023
Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
5.5 Disease Type segment analysis 2019 - 2023
Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Chronic Obstructive Pulmonary Disease Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Combination therapy - Market size and forecast 2024-2029
Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
8.4 Monotherapy - Market size and forecast 2024-2029
Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online pharmacies - Market size and forecast 2024-2029
Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Route of Administration
10.1 Market segments
Chart on Route of Administration - Market share 2024-2029 (%)
Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
10.3 Inhalation - Market size and forecast 2024-2029
Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
Chart on Inhalation - Year-over-year growth 2024-2029 (%)
Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
10.4 Oral - Market size and forecast 2024-2029
Chart on Oral - Market size and forecast 2024-2029 ($ million)
Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Chart on Oral - Year-over-year growth 2024-2029 (%)
Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.5 Injectable - Market size and forecast 2024-2029
Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Chart on Injectable - Year-over-year growth 2024-2029 (%)
Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)
11 Market Segmentation by Disease Type
11.1 Market segments
Chart on Disease Type - Market share 2024-2029 (%)
Data Table on Disease Type - Market share 2024-2029 (%)
11.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
11.3 Chronic bronchitis - Market size and forecast 2024-2029
Chart on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
Data Table on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
Chart on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
Data Table on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
11.4 Emphysema - Market size and forecast 2024-2029
Chart on Emphysema - Market size and forecast 2024-2029 ($ million)
Data Table on Emphysema - Market size and forecast 2024-2029 ($ million)
Chart on Emphysema - Year-over-year growth 2024-2029 (%)
Data Table on Emphysema - Year-over-year growth 2024-2029 (%)
11.5 Market opportunity by Disease Type
Market opportunity by Disease Type ($ million)
Data Table on Market opportunity by Disease Type ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.11 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.12 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.14 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
13.15 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
13.16 The Netherlands - Market size and forecast 2024-2029
Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
Companies covered
16.2 Company ranking index
Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
16.5 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
16.6 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
SWOT
16.7 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
SWOT
16.8 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
16.9 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key offerings
SWOT
16.10 Innoviva Inc.
Innoviva Inc. - Overview
Innoviva Inc. - Product / Service
Innoviva Inc. - Key news
Innoviva Inc. - Key offerings
SWOT
16.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
16.12 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
16.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.14 SHIONOGI Co. Ltd.
SHIONOGI Co. Ltd. - Overview
SHIONOGI Co. Ltd. - Product / Service
SHIONOGI Co. Ltd. - Key offerings
SWOT
16.15 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
SWOT
16.16 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
16.17 Theravance Biopharma Inc.
Theravance Biopharma Inc. - Overview
Theravance Biopharma Inc. - Product / Service
Theravance Biopharma Inc. - Key offerings
SWOT
16.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
Research methodology
17.5 Data procurement
Information sources
17.6 Data validation
Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 8: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 9: Executive Summary - Chart on Incremental Growth
Exhibits 10: Executive Summary - Data Table on Incremental Growth
Exhibits 11: Executive Summary - Chart on Company Market Positioning
Exhibits 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 13: Overview on criticality of inputs and factors of differentiation
Exhibits 14: Overview on factors of disruption
Exhibits 15: Impact of drivers and challenges in 2024 and 2029
Exhibits 16: Parent Market
Exhibits 17: Data Table on - Parent Market
Exhibits 18: Market characteristics analysis
Exhibits 19: Value chain analysis
Exhibits 20: Offerings of companies included in the market definition
Exhibits 21: Market segments
Exhibits 22: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 26: Historic Market Size - Data Table on Global Chronic Obstructive Pulmonary Disease Drugs Market 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
Exhibits 31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 33: Five forces analysis - Comparison between 2024 and 2029
Exhibits 34: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 37: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 38: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 39: Chart on Market condition - Five forces 2024 and 2029
Exhibits 40: Chart on Product - Market share 2024-2029 (%)
Exhibits 41: Data Table on Product - Market share 2024-2029 (%)
Exhibits 42: Chart on Comparison by Product
Exhibits 43: Data Table on Comparison by Product
Exhibits 44: Chart on Combination therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on Combination therapy - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on Combination therapy - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Combination therapy - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on Monotherapy - Market size and forecast 2024-2029 ($ million)
Exhibits 49: Data Table on Monotherapy - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Chart on Monotherapy - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on Monotherapy - Year-over-year growth 2024-2029 (%)
Exhibits 52: Market opportunity by Product ($ million)
Exhibits 53: Data Table on Market opportunity by Product ($ million)
Exhibits 54: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 55: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 56: Chart on Comparison by Distribution Channel
Exhibits 57: Data Table on Comparison by Distribution Channel
Exhibits 58: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 62: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 63: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 64: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 70: Market opportunity by Distribution Channel ($ million)
Exhibits 71: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 72: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits 73: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits 74: Chart on Comparison by Route of Administration
Exhibits 75: Data Table on Comparison by Route of Administration
Exhibits 76: Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Inhalation - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
Exhibits 80: Chart on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 81: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 83: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits 84: Chart on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits 85: Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 87: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits 88: Market opportunity by Route of Administration ($ million)
Exhibits 89: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits 90: Chart on Disease Type - Market share 2024-2029 (%)
Exhibits 91: Data Table on Disease Type - Market share 2024-2029 (%)
Exhibits 92: Chart on Comparison by Disease Type
Exhibits 93: Data Table on Comparison by Disease Type
Exhibits 94: Chart on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Chronic bronchitis - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Chronic bronchitis - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Emphysema - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Data Table on Emphysema - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Chart on Emphysema - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Emphysema - Year-over-year growth 2024-2029 (%)
Exhibits 102: Market opportunity by Disease Type ($ million)
Exhibits 103: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 107: Chart on Geographic comparison
Exhibits 108: Data Table on Geographic comparison
Exhibits 109: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibits 162: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibits 163: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibits 164: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibits 165: Market opportunity By Geographical Landscape ($ million)
Exhibits 166: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 167: Impact of drivers and challenges in 2024 and 2029
Exhibits 168: Overview on criticality of inputs and factors of differentiation
Exhibits 169: Overview on factors of disruption
Exhibits 170: Impact of key risks on business
Exhibits 171: Companies covered
Exhibits 172: Company ranking index
Exhibits 173: Matrix on companies position and classification
Exhibits 174: AstraZeneca Plc - Overview
Exhibits 175: AstraZeneca Plc - Product / Service
Exhibits 176: AstraZeneca Plc - Key news
Exhibits 177: AstraZeneca Plc - Key offerings
Exhibits 178: SWOT
Exhibits 179: Boehringer Ingelheim International GmbH - Overview
Exhibits 180: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 181: Boehringer Ingelheim International GmbH - Key news
Exhibits 182: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 183: SWOT
Exhibits 184: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 185: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 186: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 187: SWOT
Exhibits 188: Cipla Inc. - Overview
Exhibits 189: Cipla Inc. - Business segments
Exhibits 190: Cipla Inc. - Key news
Exhibits 191: Cipla Inc. - Key offerings
Exhibits 192: Cipla Inc. - Segment focus
Exhibits 193: SWOT
Exhibits 194: GlaxoSmithKline Plc - Overview
Exhibits 195: GlaxoSmithKline Plc - Business segments
Exhibits 196: GlaxoSmithKline Plc - Key news
Exhibits 197: GlaxoSmithKline Plc - Key offerings
Exhibits 198: GlaxoSmithKline Plc - Segment focus
Exhibits 199: SWOT
Exhibits 200: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits 201: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits 202: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits 203: SWOT
Exhibits 204: Innoviva Inc. - Overview
Exhibits 205: Innoviva Inc. - Product / Service
Exhibits 206: Innoviva Inc. - Key news
Exhibits 207: Innoviva Inc. - Key offerings
Exhibits 208: SWOT
Exhibits 209: Lupin Ltd. - Overview
Exhibits 210: Lupin Ltd. - Business segments
Exhibits 211: Lupin Ltd. - Key news
Exhibits 212: Lupin Ltd. - Key offerings
Exhibits 213: Lupin Ltd. - Segment focus
Exhibits 214: SWOT
Exhibits 215: Merck and Co. Inc. - Overview
Exhibits 216: Merck and Co. Inc. - Business segments
Exhibits 217: Merck and Co. Inc. - Key news
Exhibits 218: Merck and Co. Inc. - Key offerings
Exhibits 219: Merck and Co. Inc. - Segment focus
Exhibits 220: SWOT
Exhibits 221: Novartis AG - Overview
Exhibits 222: Novartis AG - Business segments
Exhibits 223: Novartis AG - Key news
Exhibits 224: Novartis AG - Key offerings
Exhibits 225: Novartis AG - Segment focus
Exhibits 226: SWOT
Exhibits 227: SHIONOGI Co. Ltd. - Overview
Exhibits 228: SHIONOGI Co. Ltd. - Product / Service
Exhibits 229: SHIONOGI Co. Ltd. - Key offerings
Exhibits 230: SWOT
Exhibits 231: Sumitomo Pharma Co. Ltd. - Overview
Exhibits 232: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits 233: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits 234: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits 235: SWOT
Exhibits 236: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 237: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 238: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 239: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 240: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 241: SWOT
Exhibits 242: Theravance Biopharma Inc. - Overview
Exhibits 243: Theravance Biopharma Inc. - Product / Service
Exhibits 244: Theravance Biopharma Inc. - Key offerings
Exhibits 245: SWOT
Exhibits 246: Viatris Inc. - Overview
Exhibits 247: Viatris Inc. - Business segments
Exhibits 248: Viatris Inc. - Key news
Exhibits 249: Viatris Inc. - Key offerings
Exhibits 250: Viatris Inc. - Segment focus
Exhibits 251: SWOT
Exhibits 252: Inclusions checklist
Exhibits 253: Exclusions checklist
Exhibits 254: Currency conversion rates for US$
Exhibits 255: Research methodology
Exhibits 256: Information sources
Exhibits 257: Data validation
Exhibits 258: Validation techniques employed for market sizing
Exhibits 259: Data synthesis
Exhibits 260: 360 degree market analysis
Exhibits 261: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global chronic obstructive pulmonary disease drugs market: AstraZeneca Plc, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CHIESI Farmaceutici SpA, Cipla Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Innoviva Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, SHIONOGI Co. Ltd., Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., Theravance Biopharma Inc., Viatris Inc., and Phillips Medisize.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is expanding research in curative approaches."

According to the report, one of the major drivers for this market is the rising prevalence of copd.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca Plc
  • Boehringer Ingelheim International GmbH
  • Cadila Pharmaceuticals Ltd.
  • CHIESI Farmaceutici SpA
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Innoviva Inc.
  • Lupin Ltd.
  • Merck and Co. Inc.
  • Novartis AG
  • SHIONOGI Co. Ltd.
  • Sumitomo Pharma Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Theravance Biopharma Inc.
  • Viatris Inc.
  • Phillips Medisize

Related Topics

Related Reports

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2025 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Treatment Market by Product Type (Antibiotics, Corticosteroids, Long Acting Bronchodilators), Drug Class (Anticholinergics, Beta Agonists, Corticosteroids), Route Of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Chronic Obstructive Pulmonary Disease Treatment Market by Product Type (Antibiotics, Corticosteroids, Long Acting Bronchodilators), Drug Class (Anticholinergics, Beta Agonists, Corticosteroids), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Chronic Obstructive Pulmonary Disease Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 343 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Therapeutics Market by Product (Antibiotics, Bronchodilators, Combination Products), Route Of Administration (Inhalation, Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Chronic Obstructive Pulmonary Disease Therapeutics Market by Product (Antibiotics, Bronchodilators, Combination Products), Route Of Administration (Inhalation, Injectable, Oral), Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.